JPRN-UMIN000035722已完成未知
A randomized, double-blind, crossover study to examine the effects of concurrent intake of alcohol and test food on cognitive function. - A study examining the effects of concurrent intake of alcohol and test food on cognitive function.
IMEQRD Co., Ltd0 个研究点目标入组 12 人开始时间: 2019年1月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.Those who have an allergy to test food ingredients. 2.Those who have a current or a past medical history of severe disease. 3.Those who are participating in another clinical trial or have participated in another clinical trial within a month. 4.In the opinion of the principal investigator, those who were determined to be unsuitable for participation in this clinical trial.
研究者
相似试验
进行中（未招募）
不适用
A randomised, double-blind, crossover study to investigate the bronchodilatation post-inhalation of GSK961081 alone and with the addition of cumulative doses of short acting bronchodilators (salbutamol and ipratropium bromide) in patients with COPDChronic Obstructive Pulmonary DiseaseEUCTR2008-000725-18-GBGlaxoSmithKline Reaseach & Development45
已完成
不适用
A double-blind, randomised, crossover study to investigate the difference in frequency of episodes of hypoglycaemia during treatment with Biphasic Insulin Aspart 30 (NovoMix®30) compared to Biphasic Human Insulin 30 (Mixtard® 30) in patients with well-controlled, type 2 diabetesType 2 diabetes requiring insulinNutritional, Metabolic, EndocrineDiabetesISRCTN34091554ovo Nordisk Ltd (UK)160
进行中（未招募）
1 期
Effect of tiotropium + olodaterol on breathlessness in COPD patientsPatients with moderate to severe Chronic Obstructive Pulmonary Disease according to the GOLD guidelines.MedDRA version: 19.0Level: LLTClassification code 10009026Term: Chronic obstructive airways diseaseSystem Organ Class: 100000004855EUCTR2015-002974-20-BESCS Boehringer Ingelheim Comm. V102
进行中（未招募）
1 期
Effect of tiotropium + olodaterol on breathlessness in COPD patientsPatients with moderate to severe Chronic Obstructive Pulmonary Disease according to the GOLD guidelines.MedDRA version: 19.0Level: LLTClassification code 10009026Term: Chronic obstructive airways diseaseSystem Organ Class: 100000004855EUCTR2015-002974-20-NLBoehringer Ingelheim bv130
已完成
4 期
A randomised, double-blind, cross-over study to evaluate the effect of 6 weeks treatment of orally inhaled tiotropium + olodaterol fixed dose combination (5/5 µg) compared with tiotropium (5 µg), both delivered by the Respimat® Inhaler, on breathlessness during the three minute Constant Speed Shuttle Test (3min CSST) in patients with Chronic Obstructive Pulmonary Disease (COPD).COPD (Chronic Obstructive Pulmonary Disease10038716NL-OMON42990Boehringer Ingelheim18